Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report.
10.9758/cpn.2015.13.3.321
- Author:
Dushad RAM
1
;
Shwetha PATIL
;
Basavana GOWDAPPA
;
Iyshwarya RAJALAKSHMI
Author Information
1. Department of Psychiatry, JSS Medical College, Mysore, India. akashji1972@gmail.com
- Publication Type:Case Report
- Keywords:
Atomoxetine augment;
Treatment resistant panic disorder;
Selective norepinephrine reuptake inhibitor
- MeSH:
Anxiety;
Attention Deficit Disorder with Hyperactivity;
Citalopram;
Clonazepam;
Norepinephrine;
Panic Disorder*;
Panic*;
Paroxetine;
Propranolol;
Risperidone;
Sertraline;
Atomoxetine Hydrochloride
- From:Clinical Psychopharmacology and Neuroscience
2015;13(3):321-323
- CountryRepublic of Korea
- Language:English
-
Abstract:
Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.
